Greylock appoints Anthony Rinaldi as Director Emeritus

Print Story | Email Story
PITTSFIELD, Mass. — Greylock Federal Credit Union's Board of Directors voted unanimously to appoint Anthony Rinaldi as Director Emeritus in recognition of his longstanding and distinguished service to the credit union.
 
In March 2024, the Board of Directors voted to confer the Director Emeritus designation on Rinaldi. Individuals who are appointed Directors Emeriti function as an advisory committee to the board of directors. Rinaldi's designation reflects a two-year term.
 
"I'm honored to have served with Tony and am gratified to recognize his years of dedication and commitment to the members of Greylock," said Board Chair Peter Lopez. "We look forward to his continued involvement with the board as an esteemed advisor and Director Emeritus."
 
Rinaldi joined the board in 1994 and served as Chairman for five years. He most recently served as chair on the Asset-Liability Committee, or ALCO, and the Compensation committee.
 
"I've known Tony for many years and it's been an honor to serve with him on our board," said Board Member Sheila A. LaBarbera. "Our board has truly benefitted from Tony's tireless service, expertise, and generosity through the years and we are thrilled to honor him in this way."
 
Rinaldi recently retired from his role as the Executive Vice President of Fairview Hospital for Berkshire Health Systems. He is a graduate of Boston College School of Management with a bachelor's degree in accounting. He lives in Pittsfield with his wife, Wendy.

Tags: Greylock Federal,   

If you would like to contribute information on this article, contact us at info@iberkshires.com.

Kratom Products Pulled From Pittsfield, Statewide Shelves

By Brittany PolitoiBerkshires.com Staff

PITTSFIELD, Mass.— The state has put an emergency yearlong order on kratom products, and Pittsfield is working with retailers to remove the product from shelves. 

Last week, Director of Public Health Andy Cambi delivered an update on the emergency order that went into effect on August 28.  Also known by its chemical name and marketed with the term "7-OH," Massachusetts temporarily designated kratom as a Schedule I drug, greatly restricting sales. 

The formerly unregulated product has resulted in emergency room visits, poison control calls, and deaths.  

"Dependency and the opioid-like withdrawal symptoms are the major key health concerns," Cambi explained. "Liver toxicity, seizures, just a greater overdose risk when combined with other substances, and then the main thing is that this is not regulated."

He said that throughout the years, retail shops have reached out to the Health Department looking for guidance on kratom products and were notified that it is unregulated. 

"And for the most part, when they hear that, they don't sell the product," he added. 

Kratom is a leafy plant native to Southeast Asia containing naturally occurring substances, including mitragynine and 7-hydroxymitragynine (7-OH).  It is marketed to relieve pain and can produce stimulating or sedating effects, depending on the amount taken and potency. Newer products contain highly concentrated or laboratory-modified compounds that can have significantly stronger opioid-like effects. 

Kratom products have been widely sold in smoke shops, convenience stores, and gas stations as powders, tablets, capsules, gummies, dissolvable strips, and in other forms.

View Full Story

More Pittsfield Stories